It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sanjay Gupta turns to his CNN colleague Meg Tirrell for answers, and a little context about the business behind these new medications.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
Atlanta Returns to School
Saying Goodbye
One Year Later
Vaccine Hesitancy in Flint, Michigan
So You’re Vaccinated ... Now What?
Instagramming the Pandemic
The Art of Caring
The New 9 to 5
Should the Games Go On?
Olympic Dreams Postponed
The Bumpy Road to Herd Immunity
Good News from Indian Country
Not So Sweet Dreams
The Latest from Wuhan
Covid’s Long Haulers
Honoring a Forgotten Medical Pioneer
Asian Americans are Americans, Too
Are We Still Uncomfortably Numb?
When Will Schools Truly Be Safe?
Vaccine FAQs
Create your
podcast in
minutes
It is Free
Newscast
Consider This from NPR
What’s That Rash?
The Coronavirus Podcast
Coronavirus Central